(Q72086607)

English

Decrease of prostatic intraepithelial neoplasia following androgen deprivation therapy in patients with stage T3 carcinoma treated by radical prostatectomy

scientific article published on 01 July 1994

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8042266%20AND%20SRC:MED&resulttype=core&format=json

23 October 2019

Decrease of prostatic intraepithelial neoplasia following androgen deprivation therapy in patients with stage T3 carcinoma treated by radical prostatectomy (English)

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8042266%20AND%20SRC:MED&resulttype=core&format=json

23 October 2019

intraepithelial neoplasia

1 reference

based on heuristic

inferred from title

prostatic intraepithelial neoplasia

1 reference

based on heuristic

inferred from title

David G. Bostwick

5

object named as

D G Bostwick

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8042266%20AND%20SRC:MED&resulttype=core&format=json

23 October 2019

author name string

J Ferguson

1

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8042266%20AND%20SRC:MED&resulttype=core&format=json

23 October 2019

H Zincke

2

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8042266%20AND%20SRC:MED&resulttype=core&format=json

23 October 2019

E Ellison

3

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8042266%20AND%20SRC:MED&resulttype=core&format=json

23 October 2019

E Bergstrahl

4

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8042266%20AND%20SRC:MED&resulttype=core&format=json

23 October 2019

language of work or name

0 references

publication date

1 July 1994

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8042266%20AND%20SRC:MED&resulttype=core&format=json

23 October 2019

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8042266%20AND%20SRC:MED&resulttype=core&format=json

23 October 2019

44

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8042266%20AND%20SRC:MED&resulttype=core&format=json

23 October 2019

91-95

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8042266%20AND%20SRC:MED&resulttype=core&format=json

23 October 2019

1

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8042266%20AND%20SRC:MED&resulttype=core&format=json

23 October 2019

Transrectal ultrasound evaluation of local prostate cancer in patients treated with LHRH agonist and in combination with flutamide

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2894%2980015-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Complete Androgen Deprivation prior to Radical Prostatectomy in Patients with Stage T(3) Cancer of the Prostate

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2894%2980015-4

7 January 2021

based on heuristic

inferred from DOI database lookup

A phase III trial of zoladex and flutamide versus orchiectomy in the treatment of patients with advanced carcinoma of the prostate

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2894%2980015-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Luteinizing hormone-releasing hormone downstaging of clinical stage C prostate cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2894%2980015-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Combination therapy with flutamide and medical (LHRH agonist) or surgical castration in advanced prostate cancer: 7-year clinical experience

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2894%2980015-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Controversies in the treatment of metastatic prostate cancer.

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2894%2980015-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Pathologic changes associated with androgen deprivation therapy for prostate cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2894%2980015-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Effect of combination endocrine therapy (LHRH agonist and flutamide) on normal prostate and prostatic adenocarcinoma. A histopathologic and immunohistochemical study.

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2894%2980015-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Intraductal dysplasia: a premalignant lesion of the prostate

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2894%2980015-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Prostatic intra-epithelial neoplasia and early invasion in prostate cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2894%2980015-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Immunohistochemical evidence for impaired cell differentiation in the premalignant phase of prostate carcinogenesis

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2894%2980015-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Squamous metaplasia of prostate following estrogen therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2894%2980015-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Response of rat and human prostatic cancers to the novel 5 alpha-reductase inhibitor, SK&F 105657

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2894%2980015-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Androgen action blockade does not result in reduction in size but changes histology of the normal human prostate

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2894%2980015-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Occurrence of cell death (apoptosis) in prostatic intra-epithelial neoplasia

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2894%2980015-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Introductory remarks: Development of chemopreventive agents for prostate cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2894%2980015-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Chemoprevention strategies for prostate cancer: The role of 5α-reductase inhibitors

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2894%2980015-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1016/S0090-4295(94)80015-4

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8042266%20AND%20SRC:MED&resulttype=core&format=json

23 October 2019

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8042266%20AND%20SRC:MED&resulttype=core&format=json

23 October 2019

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q72086607&oldid=1907336275"